AffiliationDept of Instrumentation & Analytical Science (DIAS), UMIST, PO Box 88, M60 1QD, Manchester, UK. A.J.Reader@umist.ac.uk
MetadataShow full item record
AbstractNew molecular imaging technologies are being developed specifically for imaging animal models of human disease. Positron emission tomography (PET) in particular allows in vivo biochemistry to be studied with a high degree of sensitivity and specificity, and provides direct in vivo information on molecular and cellular pathways that underlie disease mechanisms and therapeutics. However, clinical PET systems have inadequate resolution for imaging small animals. Thus, specialized high-resolution PET hardware and software are now being developed.
CitationDevelopments in whole-body molecular imaging of live subjects. 2001, 22 (12):604-7 Trends Pharmacol. Sci.
JournalTrends in Pharmacological Sciences
- [Molecular radiology. II: Molecular imaging].
- Authors: Alfke H, Nocken F, Heverhagen JT, Klose KJ
- Issue date: 2001 May
- [Pathophysiology of dementia and medical imaging].
- Authors: Yonekura Y
- Issue date: 1989 Oct
- Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
- Authors: Schmidt GP, Kramer H, Reiser MF, Glaser C
- Issue date: 2007 Jun
- Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
- Authors: Medical Advisory Secretariat.
- Issue date: 2010
- Established rheumatoid arthritis - new imaging modalities.
- Authors: McQueen FM, Ostergaard M
- Issue date: 2007 Oct